|
Our
Patents
COMPOSITIONS AND METHODS OF USE OF 8-NITROGUANINE
Patent No.: US 6,379,900 B1
Abstract
Novel methods for the synthesis of 8-nitroguanine are provided.
Compositions comprising 8-nitroguanine, made by the novel synthetic
methods are also provided herein. Methods of use of 8-nitroganine,
made by the novel synthetic methods, as a standard for detection
of 8-nitroguanine in samples are also encompassed within the scope
of the present invention. The present invention further concerns
methods of predicting organ transplant rejection and detecting exposure
to environmental stressors, such as ionizing radiation, toxic chemicals
or infectious agents, by decting 8-nitroguanine in one or more samples
from a transplant recipient or an organism exposed to stress.
[ VIEW
]
ORGANIC
SEMICONDUCTOR RECOGNITION COMPLEX AND SYSTEM
Patent No.: US 6,303,316 B1
Abstract
In a recognition complex system, nucleic acid ligands comprising
random DNA sequences are operatively coupled to an organic semiconductor
and distributed so as to form an array of recognition complexes.
When an unknown chemical or biological analyte is applied to the
array, the electrical and/or photochemical properties of one or
more of the recognition complexes are altered upon binding of the
nucleic acid ligand to the analyte. The degree to which the electrical
and/or photochemical properties change is a function of the affinity
of the nucleic acid ligand sequence for the analyte. The electrical
and photochemical changes associated with the array, as a whole,
can be used as a unique signature to identify the analyte. In certain
embodiments, an iterative process of selection and amplification
of nucleic acid ligands that bind to the analyte can be used to
generate a new array with greater affinity and specificity for a
target analyte, or to produce one or more nucleic acid ligands with
high binding affinity for an analyte. The present invention also
provides methods for preparing nucleic acid ligands that bind with
high affinity to an analyte and using such nucleic acid ligands
to neutralize the analyte.
[ VIEW
]
|